These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 9041534

  • 1. Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis.
    Matsumoto K.
    Nephron; 1997; 75(2):154-9. PubMed ID: 9041534
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Nephron; 1998; 78(4):403-9. PubMed ID: 9578066
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Am J Nephrol; 1999 Jul; 19(1):21-7. PubMed ID: 10085445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
    [Abstract] [Full Text] [Related]

  • 7. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Nephron; 1999 Feb; 82(1):32-8. PubMed ID: 10224482
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Nephron; 2000 Jun; 85(2):127-33. PubMed ID: 10867518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
    Kondo S, Yoshizawa N, Kusumi Y, Takeuchi A, Torikata C.
    Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
    [Abstract] [Full Text] [Related]

  • 12. Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome.
    Heslan JM, Branellec AI, Pilatte Y, Lang P, Lagrue G.
    Clin Exp Immunol; 1991 Oct; 86(1):157-62. PubMed ID: 1914229
    [Abstract] [Full Text] [Related]

  • 13. Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome.
    Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroume T.
    Nephron; 1985 Oct; 41(2):157-60. PubMed ID: 3876517
    [Abstract] [Full Text] [Related]

  • 14. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
    [Abstract] [Full Text] [Related]

  • 15. Increased IL-12 release by monocytes in nephrotic patients.
    Matsumoto K, Kanmatsuse K.
    Clin Exp Immunol; 1999 Aug; 117(2):361-7. PubMed ID: 10444271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant granulocyte-macrophage colony-stimulating factor modulates in vitro function of the peripheral blood mononuclear cells in lipoid nephrosis.
    Matsumoto K, Yasugi T.
    Am J Nephrol; 1993 Aug; 13(2):100-6. PubMed ID: 8342574
    [Abstract] [Full Text] [Related]

  • 18. Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis.
    Nishitani Y, Kubo A, Iwano M, Minamino N, Hamano K, Fujimoto T, Nishino T, Shiiki H, Yonemasu K, Dohi K.
    Clin Exp Immunol; 2001 May; 124(2):330-6. PubMed ID: 11422212
    [Abstract] [Full Text] [Related]

  • 19. Adrenomedullin gene transcription is decreased in peripheral blood mononuclear cells of patients with IgA nephropathy.
    Kubo A, Nishitani Y, Minamino N, Kikumoto K, Kurioka H, Nishino T, Iwano M, Shiiki H, Kangawa K, Dohi K.
    Nephron; 2000 Jul; 85(3):201-6. PubMed ID: 10867534
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF.
    Tsai JC, Goldman CK, Gillespie GY.
    J Neurosurg; 1995 May; 82(5):864-73. PubMed ID: 7714613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.